Status:
COMPLETED
CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
European Regional Development Fund
Conseil Régional Auvergne-Rhône-Alpes, Clermont-Ferrand, France.
Conditions:
Chronic Disease
Cardiovascular Diseases
Eligibility:
All Genders
35-55 years
Phase:
NA
Brief Summary
The state of health in France appears to be good with regard to major indicators such as life expectancy at birth. However, France is characterized by a high standardized rate of premature mortality ...
Detailed Description
The state of health in France appears to be good with regard to major indicators such as life expectancy at birth. However, France is characterized by a high standardized rate of premature mortality ...
Eligibility Criteria
Inclusion
- Men or women aged 35 to 55 years
- Subjects identified as moderate risk (group G1) following the assessment of the level of risk
- Covered by the Social Security
- Having signed the information form and having given his / her free consent during the inclusion visit
- Judged able to understand the aims of the study and ready to accept the constraints
Exclusion
- Age \<35 years or\> 55 years
- Person who has not completed and validated the FSI (online health questionnaire)
- Person belonging to group G1 but with a moderate pathological risk (P1) and no identifiable risk in the behavioral field (C0)
- Pregnant or lactating women
- Persons benefiting from a legal protection measure
- Persons refusing to sign information and consent form
- Person in an exclusion period from another study, or having received more than 4500 € in the year
- Person deprived of his liberty by judicial or administrative decision
- Medical or surgical history, judged by the investigator to be incompatible with the study
- Suspicion of psychiatric disorders judged by the investigator to be incompatible with the study
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2018
Estimated Enrollment :
251 Patients enrolled
Trial Details
Trial ID
NCT03378895
Start Date
December 1 2017
End Date
September 28 2018
Last Update
January 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003